title: Immunization after the elective end of antineoplastic chemotherapy in children.
abstract: The aim of the present commentary is to discuss the multifaceted topic of vaccinations after treatment for cancer in the pediatric age. Publications in this field reveal conflicting data and opinions; no evidence-based guidelines currently exist. However, in spite of several discrepancies some commonly accepted information and conclusions exist. Efforts to find a common strategy of re-immunization should be directed towards setting up prospective studies on sufficient numbers of patients to obtain statistically relevant end points.
authors.affiliation: Haematology Unit, Department of Haematology and Oncology, "G.Gaslini" Children Hospital, Genoa, Italy. francescafioredda@ospedale-gaslini.ge.it
authors.forename: Francesca
authors.initials: F
authors.lastname: Fioredda
authors.forename: Michaela
authors.initials: M
authors.lastname: Cavillo
authors.forename: Laura
authors.initials: L
authors.lastname: Banov
authors.forename: Alessandro
authors.initials: A
authors.lastname: Plebani
authors.forename: Anna
authors.initials: A
authors.lastname: Timitilli
authors.forename: Elio
authors.initials: E
authors.lastname: Castagnola
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D019317:Evidence-Based Medicine; D006801:Humans; D007114:Immunization; D009894:Opportunistic Infections / Q000139:chemically induced / Q000517:prevention & control*; D017410:Practice Guidelines as Topic
chemical_list: D000970:Antineoplastic Agents